Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FoxHollow Integration Problems Plague ev3 In First Quarter

This article was originally published in The Gray Sheet

Executive Summary

Endovascular device firm ev3's failure to meet first-quarter 2008 revenue targets is being blamed on unexpected challenges in assimilating the FoxHollow Technologies sales force

You may also be interested in...



Covidien Runs Familiar But Different Plays to Build Vascular Franchise

Covidien Ltd. continues to build its vascular global business unit with the acquisition of peripheral leader ev3 Inc.

Covidien Runs Familiar But Different Plays to Build Vascular Franchise

Covidien Ltd. continues to build its vascular global business unit with the acquisition of peripheral leader ev3 Inc.

People In Brief

Medtronic names new diabetes exec: Pediatric endocrinologist Francine Kaufman will join Medtronic's diabetes business in June as VP of global medical affairs. Kaufman, who will report to the president of the diabetes unit Chris O'Connell, will be a "key architect of the company's global diabetes strategy, as well as a leading voice for multi-disciplinary medical strategy across Medtronic," firm said in a Nov. 24 announcement. She is and will remain a professor at the University of Southern California Keck School of Medicine and is a former president of the American Diabetes Association. Kaufman succeeds Alan Marcus

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT025991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel